Evidence map›Paper›PMID 41633979›Full record

ArticleNature communications2026

An in vivo and in vitro spatiotemporal profile of human midbrain development.

Dimitri Budinger, Pau Puigdevall, George T Hall, Charlotte Roth, Theodoros Xenakis, Elena Marrosu, Julie Jerber, Alessandro Di Domenico, Francesca Picco, Helena Kilpinen and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. β-Hydroxybutyrate Exposure is Associated with Increased THCellular and molecular neurobiology · 2026
    Article
  3. Novel advanced patient-derivedFrontiers in neurology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dimitri Budinger *Developmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-7002-1091
Pau Puigdevall *Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8687-4942
George T Hall *Genetics and Genomics Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-4828-0668
Charlotte RothDevelopmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0003-0227-3339
Theodoros XenakisGenetics and Genomics Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0003-3682-8873
Elena MarrosuDevelopmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Julie JerberWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Alessandro Di DomenicoDevelopmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Francesca PiccoDevelopmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Helena KilpinenHelsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-6692-6154
Sergi CastellanoGenetics and Genomics Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Manju A KurianDevelopmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom. manju.kurian@ucl.ac.uk.ORCID http://orcid.org/0000-0003-3529-5075
Serena BarralDevelopmental Neurosciences, Zayed Centre for Research, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom. s.barral@ucl.ac.uk.ORCID http://orcid.org/0000-0002-1430-3614

Funding

Wellcome Trust
6 · The paper itself

Abstract

The dopaminergic system has key roles in human physiology and is implicated in a broad range of neurological and neuropsychiatric conditions that are increasingly investigated using induced pluripotent stem cell-derived midbrain models. To determine similarities of such models to human systems, here we undertake single-cell and spatial profiling of first and second trimester fetal midbrain and compare it to in vitro midbrain models. Histological examination reveals that, by the second trimester, fetal midbrain tissue exhibits structural complexity comparable to that of adults. At the molecular level, single-cell profiling uncovers differences in cellular composition across models, with brain organoids most closely resembling late first trimester tissue - an observation supported by meta-integration of existing midbrain datasets. By reconstructing developmental trajectories of neuronal and astrocytic lineages, we map gene expression dynamics associated with maturation. Importantly, integration of spatial transcriptomics provides critical context for aligning organoid models, revealing that their spatial organization and intercellular signaling resemble the architecture and microenvironment of the second trimester midbrain. Ultimately, we leverage our findings to study Dopamine Transporter Deficiency Syndrome progression in patient-derived midbrain organoids, validating their relevance. Understanding the extent of human tissue recapitulation in midbrain laboratory models is essential to justify their use as biological proxies.

Indexed as

MesencephalonAstrocytesDopaminergic NeuronsFemaleFetusGene Expression Regulation, DevelopmentalHumansInduced Pluripotent Stem CellsNeurodevelopmentOrganoidsPregnancyPregnancy Trimester, FirstPregnancy Trimester, SecondSingle-Cell AnalysisSpatial TranscriptomicsTranscriptome

Identifiers

PMID41633979
PMCPMC12877092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.